NAS:ZGNX (USA) Also trade in: Germany

Zogenix Inc

$ 38.15 -0.87 (-2.23%)
Volume: 536,804 Avg Vol (1m): 802,642
Market Cap $: 1.62 Bil Enterprise Value $: 1.14 Bil
P/E (TTM): 0.00 P/B: 3.25
Earnings Power Value 5.03
Net Current Asset Value 8.69
Tangible Book 9.19
Projected FCF -8.12
Median P/S Value 0
Graham Number 0
Peter Lynch Value 0
DCF (FCF Based) 0
DCF (Earnings Based) 0
1Y (-%)

Financial Strength : 7/10

GuruFocus Financial Strength Rank measures how strong a company's financial situation is . It is based on these factors
1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.
A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.
Current vs industry vs history
Cash-to-Debt No Debt
Cash-To-Debt ranked higher than
94.62% of 1078 companies
in the Biotechnology industry.
Industry Max: 20856.43, Med: 64.02, Min: 0.01
ZGNX: No Debt
Ranked among companies with meaningful Cash-To-Debt only.
Cash-To-Debt range over the past 10 years
Min: 0.29, Med: 2.71, Max: 10000
Current: 10000
0.29
10000
Piotroski F-Score 3
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 5.19
DISTRESS
GREY
SAFE
Beneish M-Score -2.24
Not Manipulator
Manipulator
WACC vs ROIC %
ROIC -2216.76%
WACC 15.3%

Profitability & Growth : 3/10

GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way.
Current vs industry vs history
ROE % -30.52
ROE ranked lower than
72.50% of 989 companies
in the Biotechnology industry.
Industry Max: 326.78, Med: -42.82, Min: -100794.12
ZGNX: -30.52
Ranked among companies with meaningful ROE only.
ROE range over the past 10 years
Min: -491.54, Med: -53, Max: 23.3
Current: -30.52
-491.54
23.3
ROA % -23.57
ROA ranked lower than
69.00% of 1084 companies
in the Biotechnology industry.
Industry Max: 224.74, Med: -34.77, Min: -3751.92
ZGNX: -23.57
Ranked among companies with meaningful ROA only.
ROA range over the past 10 years
Min: -89.81, Med: -45.67, Max: 10.28
Current: -23.57
-89.81
10.28
ROC (Joel Greenblatt) % -4831.09
ROC (Joel Greenblatt) ranked lower than
82.05% of 1036 companies
in the Biotechnology industry.
Industry Max: 641137.84, Med: -521.46, Min: -3427023.81
ZGNX: -4831.09
Ranked among companies with meaningful ROC (Joel Greenblatt) only.
ROC (Joel Greenblatt) range over the past 10 years
Min: -7942.86, Med: -412.57, Max: 547.3
Current: -4831.09
-7942.86
547.3
3-Year Total Revenue Growth Rate -100.00
3-Year Revenue Growth Rate ranked lower than
100.00% of 651 companies
in the Biotechnology industry.
Industry Max: 906.3, Med: 1.1, Min: -100
ZGNX: -100
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
3-Year Revenue Growth Rate range over the past 10 years
Min: 0, Med: -50.8, Max: -21.8
Current: -100
0
-21.8
3-Year Total EBITDA Growth Rate -32.70
3-Year EBITDA Growth Rate ranked lower than
100.00% of 802 companies
in the Biotechnology industry.
Industry Max: 1406.7, Med: 4.6, Min: -2038.5
ZGNX: -9.7
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
3-Year EBITDA Growth Rate range over the past 10 years
Min: 0, Med: 8.3, Max: 76
Current: -9.7
0
76
3-Year EPS w/o NRI Growth Rate -19.00
3-Year EPS w/o NRI Growth Rate ranked lower than
100.00% of 763 companies
in the Biotechnology industry.
Industry Max: 1406.7, Med: 5.7, Min: -2103.4
ZGNX: -19
Ranked among companies with meaningful 3-Year EPS w/o NRI Growth Rate only.
N/A

» ZGNX's 30-Y Financials

Financials (Next Earnings Date: 2019-08-06)

Guru Trades Click for details

» Details

Insider Trades

SEC Filings

Gurus Latest Trades with NAS:ZGNX

» Interactive Chart

Peter Lynch Chart

Business Description

Industry Biotechnology » Biotechnology    NAICS : 325412    SIC : 2834
Compare NAS:ZLAB NAS:MDGL NAS:ATRA NAS:BOLD NAS:ENTA NAS:ARWR NAS:ORTX BOM:539268 SZSE:002287 NAS:XNCR OCSE:ALK B NAS:ALLK NAS:RUBY NYSE:CBM XKRX:006280 NAS:CORT NAS:ALEC NAS:IOVA SZSE:002030 NAS:INVA
Traded in other countries Z081.Germany
Address 5858 Horton Street, Suite 455, Emeryville, CA, USA, 94608
Zogenix Inc is a pharmaceutical company engaged in commercializing and developing therapies that address clinical needs for people living with pain-related and CNS disorders that needs treatment alternatives to help return to normal daily functioning.

Ratios

Current vs industry vs history
PB Ratio 3.25
PB Ratio ranked lower than
69.75% of 962 companies
in the Biotechnology industry.
Industry Max: 2236, Med: 4.1, Min: 0.05
ZGNX: 3.25
Ranked among companies with meaningful PB Ratio only.
PB Ratio range over the past 10 years
Min: 1.15, Med: 4.86, Max: 543.53
Current: 3.25
1.15
543.53
EV-to-EBIT -8.24
EV-to-EBIT ranked lower than
100.00% of 261 companies
in the Biotechnology industry.
Industry Max: 4391.42, Med: 22.17, Min: 0.02
ZGNX: -8.24
Ranked among companies with meaningful EV-to-EBIT only.
EV-to-EBIT range over the past 10 years
Min: -20.4, Med: -3.3, Max: 5.1
Current: -8.24
-20.4
5.1
EV-to-EBITDA -8.25
EV-to-EBITDA ranked lower than
100.00% of 281 companies
in the Biotechnology industry.
Industry Max: 28816.43, Med: 18.08, Min: 0.02
ZGNX: -8.25
Ranked among companies with meaningful EV-to-EBITDA only.
EV-to-EBITDA range over the past 10 years
Min: -21.8, Med: -3.4, Max: 5
Current: -8.25
-21.8
5
Current Ratio 9.12
Current Ratio ranked higher than
88.08% of 1074 companies
in the Biotechnology industry.
Industry Max: 3987.61, Med: 4.46, Min: 0.01
ZGNX: 9.12
Ranked among companies with meaningful Current Ratio only.
Current Ratio range over the past 10 years
Min: 0.85, Med: 2.22, Max: 14.52
Current: 9.12
0.85
14.52
Quick Ratio 9.12
Quick Ratio ranked higher than
89.66% of 1074 companies
in the Biotechnology industry.
Industry Max: 3987.61, Med: 4.18, Min: 0.01
ZGNX: 9.12
Ranked among companies with meaningful Quick Ratio only.
Quick Ratio range over the past 10 years
Min: 0.32, Med: 1.83, Max: 14.52
Current: 9.12
0.32
14.52

Dividend & Buy Back

Current vs industry vs history
3-Year Share Buyback Rate -15.20
3-Year Share Buyback Rate ranked lower than
52.28% of 857 companies
in the Biotechnology industry.
Industry Max: 43.5, Med: -13.4, Min: -1815.4
ZGNX: -15.2
Ranked among companies with meaningful 3-Year Share Buyback Rate only.
3-Year Share Buyback Rate range over the past 10 years
Min: -348.1, Med: -29.1, Max: -12.6
Current: -15.2
-348.1
-12.6

Valuation & Return

Current vs industry vs history
Price-to-Tangible-Book 4.15
Price-to-Tangible-Book ranked lower than
72.82% of 894 companies
in the Biotechnology industry.
Industry Max: 800, Med: 5.32, Min: 0.05
ZGNX: 4.15
Ranked among companies with meaningful Price-to-Tangible-Book only.
Price-to-Tangible-Book range over the past 10 years
Min: 2.82, Med: 7.23, Max: 470.59
Current: 4.15
2.82
470.59
Earnings Yield (Joel Greenblatt) % -12.13
Earnings Yield (Greenblatt) ranked lower than
66.79% of 1081 companies
in the Biotechnology industry.
Industry Max: 5000, Med: -7.73, Min: -10000
ZGNX: -12.13
Ranked among companies with meaningful Earnings Yield (Greenblatt) only.
Earnings Yield (Greenblatt) range over the past 10 years
Min: -121.9, Med: -26.6, Max: 70.3
Current: -12.13
-121.9
70.3

More Statistics

Analyst Estimate

Piotroski F-Score Details

Piotroski F-Score 3
Positive ROA N
Positive CFROA N
Higher ROA yoy Y
CFROA > ROA Y
Lower Leverage yoy Y
Higher Current Ratio yoy N
Less Shares Outstanding yoy N
Higher Gross Margin yoy N
Higher Asset Turnover yoy N